SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.360
0.00 (0.00%)
Jul 31, 2026, 4:08 PM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 1.89 billion as of July 31, 2026. Its market cap has decreased by -55.52% in one year.
Market Cap
1.89B
Enterprise Value
1.84B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.36
ChartMarket Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.89B, a decrease of -68.76%. That is a compound annual growth rate of -15.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.89B | 1.49% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Antengene Corporation | 2.68B |
| TYK Medicines | 2.62B |
| Clover Biopharmaceuticals | 2.60B |
| Laekna | 2.56B |
| BioDlink International Company | 2.48B |
| Frontage Holdings | 2.37B |
| PegBio | 2.10B |
| AIM Vaccine | 1.77B |